VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $434,000 | -19.8% | 2,433 | 0.0% | 0.08% | -12.6% |
| Q2 2015 | $541,000 | -1.5% | 2,433 | -11.9% | 0.09% | +2.4% |
| Q1 2015 | $549,000 | +29.8% | 2,761 | -6.8% | 0.08% | +28.8% |
| Q4 2014 | $423,000 | +8.7% | 2,961 | 0.0% | 0.07% | +4.8% |
| Q3 2014 | $389,000 | +4.0% | 2,961 | 0.0% | 0.06% | +8.6% |
| Q2 2014 | $374,000 | -59.8% | 2,961 | -58.1% | 0.06% | -61.8% |
| Q1 2014 | $931,000 | +13.4% | 7,063 | +1.0% | 0.15% | +5.6% |
| Q4 2013 | $821,000 | +17.5% | 6,993 | +4.3% | 0.14% | +3.6% |
| Q3 2013 | $699,000 | +35.7% | 6,703 | +12.0% | 0.14% | +35.0% |
| Q2 2013 | $515,000 | – | 5,984 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |